# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-007570
Filing Date
2021-11-04
Accepted
2021-11-04 16:41:59
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | bcrx20210930_10q.htm iXBRL | 10-Q | 1383752
2 | EXHIBIT 10.7 | ex_299565.htm | EX-10.7 | 1197
3 | EXHIBIT 10.8 | ex_299566.htm | EX-10.8 | 11283
4 | EXHIBIT 10.9 | ex_299567.htm | EX-10.9 | 11244
5 | EXHIBIT 10.10 | ex_299598.htm | EX-10.10 | 11257
6 | EXHIBIT 31.1 | ex_299568.htm | EX-31.1 | 11979
7 | EXHIBIT 31.2 | ex_299569.htm | EX-31.2 | 11878
8 | EXHIBIT 32.1 | ex_299570.htm | EX-32.1 | 4401
9 | EXHIBIT 32.2 | ex_299571.htm | EX-32.2 | 4390
15 |  | exh107_1.jpg | GRAPHIC | 181740
16 |  | exh107_2.jpg | GRAPHIC | 44666
| Complete submission text file | 0001171843-21-007570.txt |  | 6792927

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA | bcrx-20210930.xsd | EX-101.SCH | 60291
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | bcrx-20210930_cal.xml | EX-101.CAL | 37297
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | bcrx-20210930_def.xml | EX-101.DEF | 425711
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bcrx-20210930_lab.xml | EX-101.LAB | 407316
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bcrx-20210930_pre.xml | EX-101.PRE | 439098
17 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx20210930_10q_htm.xml | XML | 961337

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 211380546
SIC: 2836 Biological Products, (No Diagnostic Substances)